First Class Post Graduate Degree, including the integrated PG degree in Science, Public Health, Life Sciences OR Second Class Post Graduate Degree, including the integrated PG degree with PhD Science, Public Health, Life Sciences
Leads Pharmacovigilance and Risk Management Planning and develops strategy for approach to evaluation of issues in the clinical matrix. Leads the safety component of global regulatory submissions.
M.Sc, M.S. Pharm.,M.Pharm. in Biochemistry, Microbiology, Biotechnology, Life Sciences. Minimum CGPA of 6.75 for General category, OBC, 6.25 for SC. ST, 5.75 for persons with disability candidates on a 10 point scale in the qualifying examination.
Masters Degree in Science with specialization in Biotechnology, Genetics and Plant Breeding, Molecular Biology, life sciences from a recognized University or equivalent.
Expertise in Virus Propagation, Cell-Culture, Protein Purification, Immuno-analytical Methods, Microbial Fermentation, Molecular Biology. Experience in human vaccines development is a plus.
Post graduate Degree or PhD in Life Sciences, Pharmacology and Biomedical engineering with experience three years in conducting large scale intervention studies.
National Institute of Pharmaceutical Education and Research (NIPER - Raebareli) is an autonomous body which has been established under the aegis of the Department of pharmaceuticals, Ministry of Chemicals and Fertilizers, in the Government of India, to provide leadership in pharmaceutical Sciences and other related areas. It admits students for M.S (Pharm), programmes in Medicinal Chemistry, Pharmaceutics, Pharmacology & Toxicology, Regulatory Toxicology and Biotechnology every year.
The candidates should possess M.Sc Life sciences, Toxicology, M.S. Pharm. or M.Pharm. in Pharmacology or Pharmacology and Toxicology, Biotechnology PG degree in other relevant branches of life sciences.